Astrazeneca Pharma India Limited, a active public limited company, was established on 11 July 1979 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24231KA1979PLC003563. Registered under ROC Roc Bangalore. it is listed on BSE: 506820 and NSE: ASTRAZEN. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.
Formerly known as Astra Idl Limited. It upholds a compliant status. In 2023, it reported revenue of ₹1,029.07 Cr and a net worth of ₹588.69 Cr. Employing 935 professional, Its leadership includes Revathy Ashok (Director), Hooi Bien Chuah (Director), Bhavana Agrawal (Cfo). Past directors included Sanjeev Kumar Panchal, Nurani Ramachandran Srinivasan, Rajesh Marwaha. It holds no open charges and ₹62.50 Cr settled loans. Its latest AGM occurred on 14 August 2025, with the balance sheet filed on 31 March 2025. It is based at Block N1, 12Th Floor,Manyata Embassy Business Park Rachenahalli, Outer Ring Road, Bangalore, Karnataka, 560045.
L24231KA1979PLC003563
003563
11 July 1979
₹5.00 Cr
₹5.00 Cr
Roc Bangalore
Listed (BSE: 506820, NSE: ASTRAZEN)
Active
Explore comprehensive insights into Astrazeneca Pharma India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Revathy Ashok | Director | 02 Dec 2016 | Current |
| Hooi Bien Chuah | Director | 09 Nov 2023 | Current |
| Bhavana Agrawal | Cfo | 01 Oct 2023 | Current |
| Sylvia Lorena Varela Ramon | Director | 21 Dec 2023 | Current |
| Jesus Javier Diaz Ropero Esteso | Director | 13 Nov 2024 | Current |
| Monica Widhani | Director | 25 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Jan 2023 | Past |
| Pramod Abcsdd | Company Secretary | 31 Jul 2011 | Past |
| Pramod Abcsdd | Additional Director | 13 Sep 2017 | Past |
| Pramod Abcsdd | Director | 06 Feb 2019 | Past |
| Pramod Abcsdd | Director | 02 Dec 2016 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Astrazeneca Pharma India Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.44% increase. The company also saw a substantial improvement in profitability, with a 61.19% increase in profit. The company's net worth Soared by an impressive increase of 15.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Astrazeneca Pharma India had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹625,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jan 2008 | Il & Fs Trust Company Limited | ₹62.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Astrazeneca Pharma India has a workforce of 935 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Astrazeneca Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astrazeneca Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Astrazeneca Pharma India Limited last Annual general meeting of members was held on 14 Aug 2025 as per latest MCA records. was recorded as a recent event.
Progress on Praveen Rao Akkinepally was appointed as a Managing Director was appointed as a Managing Director on 01 Jul 2025 & has been associated with this company since 5 months 1 day . was documented.
Astrazeneca Pharma India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
Jesus Javier Diaz Ropero Esteso was appointed as a Director was appointed as a Director on 13 Nov 2024 & has been associated with this company since 1 year 17 days . was recorded as a recent event.
The activity Monica Widhani was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Bhavana Agrawal was appointed as a CFO was appointed as a CFO on 15 Mar 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
The CIN of Astrazeneca Pharma India Limited is L24231KA1979PLC003563.
Astrazeneca Pharma India Limited is headquartered at Block N1, 12Th Floor,Manyata Embassy Business Park Rachenahalli, Outer Ring Road, Bangalore, Karnataka, 560045.
Astrazeneca Pharma India Limited was incorporated on 11 July 1979.
The current directors of Astrazeneca Pharma India Limited are
The primary industry of Astrazeneca Pharma India Limited is Manufacturing.
Astrazeneca Pharma India Limited is listed. It is listed on BSE: 506820 and NSE: ASTRAZEN.
The authorized capital of Astrazeneca Pharma India Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.
The compliance status of Astrazeneca Pharma India Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX